We would love to hear your thoughts about our site and services, please take our survey here.
I agree we have a significant period of time to wait, but RM has always referred to news or trials as the financial year not calendar year. So no guarantee it will be December either.
I was sat in the second row and heard no such statement
The absolutely did narrow it down to winter, but the message below states they confirmed December which isn’t accurate.
I don’t think they did confirm any specifics around timeline. H2 still stands.
https://main.hercjobs.org/jobs/17051170/project-director
Read this and then tell me if you still have doubts we’re on STRIVE.
The Project Director will be the key staff leader for our ARDS and Sepsis Research Group. The projects are active at UCSF Parnassus Medical Center, Zuckerberg San Francisco General Hospital, and UCSF Fresno Medical Center. The projects include prospective studies of (1) patients with sepsis and acute respiratory failure (EARLI, Early Acute Renal and Lung Injury); (2) COVID-19 hospitalized patients (COMET);(3) intensive care unit patients for several studies, with biologic sample banking; as well as clinical trials including (4) ongoing NIH and Dept. of Defense clinical trial of Mesenchymal Stromal Cells for ARDS (acute respiratory distress syndrome); (5) ongoing NIH trial (ASTER) testing Vitamin C and Acetaminophen versus placebo in patients with sepsis and hypoxemia (screening and enrollment in the Emergency Dept. and the ICUs); (6) ongoing and new NIH trials of new therapies for moderate to severe illness in COVID-19 in hospitalized patients; (7) new NIH network (STRIVE) to run clinical trials for hospitalized patients with COVID-19, influenza, or bacterial pneumonia; (8) ongoing Quantum iSPY trial of new therapies for COVID-19 in hospitalized patients with moderate to severe hypoxemia.
After the BOD comments today and the emphasis they placed on broad spectrum and ability to treat multiple viruses. I think it may be the new Strive platform trial. That may just be a shot in the dark, but interesting all the same.
Maybe the biggest one of them all missing from the Q&A happy to add on.
Q do you see Synairgen treating patients in a hospital either in the UK or USA this winter?
A RM I would envisage yes, I’m happy to say I strongly envisage we will be. Subject to ongoing discussions.
I question the 33.5% for PI's. Another chat group I am a member of did a rough calculation and between everyone around 15% of all issued shares are held.
Elsol- The Hambledon link was picked up on another board around mid December. It was found to be most likely a Christmas Gift to staff.
Woodstock, I'm sure she will be disappointed you never asked. That's what every nurse in the NHS desires, each and every patient sexualising them in their place of work.
Your a Creep
I don't call death a minimal side effect, or heart inflammation in kids. What about a cheeky brain clot to add to the mix. I'm sure those people wouldn't think the side effects were minimal.
Andyandmax- Stop trumping that nonsense. The NHS is chronically underfunded. Nurses earn less than teachers, the also don't get anywhere near the same time off.
What about the people that have had 2 jabs? they're now being told it has no relevance with Omicron and only a 3rd will help. Should they also be charged if they don't take the 3rd? what about the immunosuppressed that are now having a 4th jab should they be charged if they don't want that? Where does it end? People who drink alcohol put the biggest strain on A&E Departments nationwide, do we introduce a charge for them, after all it is their choice to drink.
Fruits, Just to be clear I would happily pay for my own medical care. Unfortunately I'm currently paying forced subscriptions to the NHS of over £3000 a month through my Tax. I choose not to take the Vaccine, I don't have that luxury with tax.
Woody I thought you were taking a few weeks off. The truth is nobody knows where this share is going short term. Making wild predictions helps no-one. All we can say is it will either go up or go down.
*they advertise.
Kevinl1977- You my friend have just lost all credibility, Polygon are event nd results driven. They are most definitely only in SNG to make a large and relatively quick return, they're also not LTH's as suggested. Please refer to the investment strategy to advertise.
Ndn71- your logic makes no sense. there is no difference in typing A2 P2 or A2 A3. Other than you'll be referring to the correct trials.
https://fnih.org/sites/default/files/2021-10/ACTIV-2_v7.0-wLOA%20073021.pdf